CDC Grant will enable new research addressing maternal and child health racial disparities in Wisconsin. ST. PAUL, Minn. and AUSTIN,...
The medical software company closes the care gap in reproductive health by providing clinical decision support and virtual care pathways. ...
With half of employers looking to improve workforce understanding of benefits, GuardianWell will enhance benefits utilization by offering relevant wellness...
Reunion to Sponsor Scholarships that will Train Healthcare Professionals on Maternal Mental Health Disorders, including Postpartum Depression Reunion’s Phase 2...
New funds will fuel growth of Maven's end-to-end platform, with a focus on scaling its fertility & family building program,...
Get Well's whole health digital screening and navigation programs utilized in partnerships to facilitate health equity and whole-person care BETHESDA,...
ISTANBUL, TURKEY / ACCESSWIRE / October 5, 2024 / ClinMedica, a notable medical clinic based in Istanbul, is making strides...
Fashionable smartwatches are packed with essential health, fitness and connectivity features to help you look and feel good 24/7 OLATHE, Kan.,...
GE HealthCare’s FDA-approved flurpiridaz F 18 PET radiotracer, Flyrcado, delivers higher diagnostic efficacy in patients with known or suspected coronary...
Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on two landmark...
Aesthetic Surgery Center excels in Naples' 2024 Community's Choice Awards, earning top honors for its expertise in facial and body...
TEL AVIV, Israel, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Holdco Nuvo Group D.G Ltd (“Nuvo”), a pioneer in remote pregnancy...
NOVATO, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it will present seven...
$185+ million in incremental orders for ACAM2000® and VIGIV to be delivered in 2024 and 2025GAITHERSBURG, Md., Sept. 25, 2024...
The pre-competitive scientific research consortium of top pharmaceutical companies remains a critical force in advancing qualified PBPK modeling and simulation...
Oral and poster presentations of results from Study 501 evaluating lumateperone 42 mg as an adjunctive therapy to antidepressants for...
As a leader in neuroscience, Teva remains committed to helping address unmet needs in the treatment of schizophrenia through scientific...
Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age...
Recommendation based on a Phase 3 trial showing a significantly greater proportion of children on Dupixent achieved histological remission compared...
New solution is the first holistic program available in a digital app to help women manage the postpartum period BOSTON,...